본문 바로가기
KERD
논문KCI 등재

Epidemiology and Disease Burden of Respiratory Syncytial Virus Infection in Adults

최상호|Kim Taeeun
대한감염학회 (The Korean Society Of Infectious Diseases)|2024.03|Infection and Chemotherapy|제56권 제1호|pp. 1-12|DOI 10.3947/ic.2024.0011

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

ElderlyEpidemiologyRespiratory syncytial virusRSV vaccineDisease burden
주제분류내과학

초록

Respiratory syncytial virus (RSV) constitutes a significant cause of respiratory illness and mortality among older adults, a demographic that is expanding with considerable impact on healthcare systems worldwide. The actual burden of RSV in this population may still be underestimated, owing to factors such as low awareness and suboptimal diagnostic sensitivity in adults, the lack of robust RSV surveillance systems, and the infrequent use of diagnostic testing. Recent advancements in respiratory virus detection have spurred further exploration into appropriate preventive and therapeutic strategies. The recent approval of two vaccines highlights the critical need for the precise estimation of the RSV disease burden to optimize the effectiveness and cost-efficiency of immunization programs. This narrative review aimed to summarize the existing knowledge of the RSV burden in adults with a particular focus on older adults, incorporating data from Korea. Overall, current estimates indicate that the annual RSV attack rate in the general adult population ranges from 1 - 7%, increasing to approximately 4 - 10% among elderly and high-risk groups. The in-hospital mortality rate can be estimated to be around 7 - 10%, rising up to 40% among intensive care unit-admitted patients. To elucidate RSV’s disease burden, further continuing research, including population-based studies, is necessary.

Abstract

Respiratory syncytial virus (RSV) constitutes a significant cause of respiratory illness and mortality among older adults, a demographic that is expanding with considerable impact on healthcare systems worldwide. The actual burden of RSV in this population may still be underestimated, owing to factors such as low awareness and suboptimal diagnostic sensitivity in adults, the lack of robust RSV surveillance systems, and the infrequent use of diagnostic testing. Recent advancements in respiratory virus detection have spurred further exploration into appropriate preventive and therapeutic strategies. The recent approval of two vaccines highlights the critical need for the precise estimation of the RSV disease burden to optimize the effectiveness and cost-efficiency of immunization programs. This narrative review aimed to summarize the existing knowledge of the RSV burden in adults with a particular focus on older adults, incorporating data from Korea. Overall, current estimates indicate that the annual RSV attack rate in the general adult population ranges from 1 - 7%, increasing to approximately 4 - 10% among elderly and high-risk groups. The in-hospital mortality rate can be estimated to be around 7 - 10%, rising up to 40% among intensive care unit-admitted patients. To elucidate RSV’s disease burden, further continuing research, including population-based studies, is necessary.

참고문헌 (83)

  1. Li Y, "Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019 : a systematic analysis", Lancet, 399, pp.2047~2064 (2022)
  2. Coultas JA, "Respiratory syncytial virus(RSV) : a scourge from infancy to old age", Thorax, 74, pp.986~993 (2019)
  3. "Respiratory syncytial virus (RSV) surveillance and research" (2023)[URL]
  4. Kim HY, "Respiratory syncytial virus infection and the need for immunization in Korea", Expert Rev Vaccines, 22, pp.327~340 (2023)
  5. Noyola DE, "Effect of climatological factors on respiratory syncytial virus epidemics", Epidemiol Infect, 136, pp.1328~1332 (2008)
  6. Kaler J, "Respiratory syncytial virus : a comprehensive review of transmission, pathophysiology, and manifestation", Cureus, 15, pp.e36342~ (2023)
  7. Abu-Raya B, "Why has the epidemiology of RSV changed during the COVID-19 pandemic?", EClinicalMedicine, 61, pp.102089~ (2023)
  8. Chow EJ, "The effects of the COVID-19 pandemic on community respiratory virus activity", Nat Rev Microbiol, 21, pp.195~210 (2023)
  9. Kim JH, "Respiratory syncytial virus outbreak without influenza in the second year of the coronavirus disease 2019 pandemic : a national sentinel surveillance in Korea, 2021-2022 season", J Korean Med Sci, 37, pp.e258~ (2022)
  10. "FDA approves first respiratory syncytial virus (RSV) vaccine" (2023)[URL]
  11. Sáez-López E, "Performance of surveillance case definitions for respiratory syncytial virus infections through the sentinel influenza surveillance system, Portugal, 2010 to 2018", Euro Surveill, 24, pp.1900140~ (2019)
  12. Chanock R, "Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent(CCA). I. Isolation, properties and characterization", Am J Hyg, 66, pp.281~290 (1957)
  13. Meissner HC, "Principles and Practice of Pediatric Infectious Diseases", pp.1162~1165 (2018), Elsevier
  14. Hall CB, "Respiratory syncytial virus infections within families", N Engl J Med, 294, pp.414~419 (1976)
  15. Hart RJ, "An outbreak of respiratory syncytial virus infection in an old people’s home", J Infect, 8, pp.259~261 (1984)
  16. Sorvillo FJ, "An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly", J Infect, 9, pp.252~256 (1984)
  17. Brandt CD, "Epidemiology of respiratory syncytial virus infection in Washington, D. C. 3. Composite analysis of eleven consecutive yearly epidemics", Am J Epidemiol, 98, pp.355~364 (1973)
  18. "Project GERi study"[URL]
  19. Staadegaard L, "Defining the seasonality of respiratory syncytial virus around the world : National and subnational surveillance data from 12 countries", Influenza Other Respir Viruses, 15, pp.732~741 (2021)
  20. Staadegaard L, "The global epidemiology of RSV in community and hospitalized care : findings from 15 countries", Open Forum Infect Dis, 8, pp.ofab159~ (2021)
  21. Du Y, "Global burden and trends of respiratory syncytial virus infection across different age groups from 1990 to 2019 : a systematic analysis of the global burden of disease 2019 study", Int J Infect Dis, 135, pp.70~76 (2023)
  22. "KDCA infectious disease portal"[URL]
  23. Pangesti KNA, "Respiratory syncytial virus in the Western Pacific Region : a systematic review and meta-analysis", J Glob Health, 9, pp.020431~ (2019)
  24. Kim JM, "Nation-wide surveillance of human acute respiratory virus infections between 2013 and 2015 in Korea", J Med Virol, 90, pp.1177~1183 (2018)
  25. Kim JK, "Epidemiology of respiratory viral infection using multiplex rt-PCR in Cheonan, Korea(2006-2010)", J Microbiol Biotechnol, 23, pp.267~273 (2013)
  26. Ko DH, "Analysis of respiratory viral infections detected using multiplex real-time PCR in Hwaseong, Korea from 2013 to 2015", Clin Lab, 63, pp.1003~1007 (2017)
  27. Kim SH, "Epidemiology of respiratory viral infection in 2004-2006", Korean J Lab Med, 26, pp.351~357 (2006)
  28. Kim GY, "Investigation of occurrence patterns of respiratory syncytial virus A and B in infected-patients from Cheonan, Korea", Respir Res, 21, pp.191~ (2020)
  29. Choi HS, "Laboratory-based surveillance of hospital-acquired respiratory virus infection in a tertiary care hospital", Am J Infect Control, 45, pp.e45~e47 (2017)
  30. Yun KW, "Molecular epidemiology of respiratory syncytial virus for 28 consecutive seasons(1990-2018)and genetic variability of the duplication region in the G gene of genotypes ON1 and BA in South Korea", Arch Virol, 165, pp.1069~1077 (2020)
  31. Kim T, "Epidemiology and characteristics of respiratory syncytial virus pneumonia in critically ill adults", Open Forum Infect Dis, 10, pp.ofad131~ (2023)
  32. Korsun N, "Predominance of ON1 and BA9 genotypes of respiratory syncytial virus(RSV)in Bulgaria, 2016-2018", J Med Virol, 93, pp.3401~3411 (2021)
  33. Tabatabai J, "Molecular epidemiology of respiratory syncytial virus in hospitalised children in Heidelberg, Southern Germany, 2014-2017", Infect Genet Evol, 98, pp.105209~ (2022)
  34. Tin Tin Htar M, "The burden of respiratory syncytial virus in adults : a systematic review and meta-analysis", Epidemiol Infect, 148, pp.e48~ (2020)
  35. "RSV in older adults and adults with chronic medical conditions"[URL]
  36. Shi T, "Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015 : a systematic review and meta-analysis", J Infect Dis, 222(Suppl 7), pp.S577~S583 (2020)
  37. Nguyen-Van-Tam JS, "Burden of respiratory syncytial virus infection in older and high-risk adults : a systematic review and meta-analysis of the evidence from developed countries", Eur Respir Rev, 31, pp.220105~ (2022)
  38. Savic M, "Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries : a systematic literature review and meta-analysis", Influenza Other Respir Viruses, 17, pp.e13031~ (2023)
  39. Falsey AR, "Respiratory syncytial virus infection in elderly and high-risk adults", N Engl J Med, 352, pp.1749~1759 (2005)
  40. Belongia EA, "Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults ≥60 years old", Open Forum Infect Dis, 5, pp.ofy316~ (2018)
  41. Juhn YJ, "Incidence of respiratory syncytial virus infection in older adults before and during the COVID-19 pandemic", JAMA Netw Open, 6, pp.e2250634~ (2023)
  42. Korsten K, "Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe(RESCEU) : an international prospective cohort study", Eur Respir J, 57, pp.2002688~ (2021)
  43. Kurai D, "Occurrence and disease burden of respiratory syncytial virus and other respiratory pathogens in adults aged ≥65 years in community : A prospective cohort study in Japan", Influenza Other Respir Viruses, 16, pp.298~307 (2022)
  44. Noh JY, "Laboratory surveillance of influenza-like illness in seven teaching hospitals, South Korea : 2011-2012 season", PLoS One, 8, pp.e64295~ (2013)
  45. Seo KH, "Prevalence of respiratory viral infections in Korean adult asthmatics with acute exacerbations : comparison with those with stable state", Allergy Asthma Immunol Res, 9, pp.491~498 (2017)
  46. Kwon JM, "Prevalence of respiratory viral infection in children hospitalized for acute lower respiratory tract diseases, and association of rhinovirus and influenza virus with asthma exacerbations", Korean J Pediatr, 57, pp.29~34 (2014)
  47. Yoon JG, "Clinical characteristics and disease burden of respiratory syncytial virus infection among hospitalized adults", Sci Rep, 10, pp.12106~ (2020)
  48. Pastula ST, "Hospitalizations for respiratory syncytial virus among adults in the United States, 1997-2012", Open Forum Infect Dis, 4, pp.ofw270~ (2017)
  49. Walsh E, "RSV-associated hospitalization in adults in the USA : A retrospective chart review investigating burden, management strategies, and outcomes", Health Sci Rep, 5, pp.e556~ (2022)
  50. Schmidt H, "Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus : a 6-year retrospective study", Influenza Other Respir Viruses, 13, pp.331~338 (2019)
  51. Maggi S, "Rate of hospitalizations and mortality of respiratory syncytial virus infection compared to influenza in older people : a systematic review and meta-analysis", Vaccines(Basel), 10, pp.2092~ (2022)
  52. Descamps A, "In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019 : an observational study", Eur Respir J, 59, pp.2100651~ (2022)
  53. Celante H, "Prognosis of hospitalised adult patients with respiratory syncytial virus infection : a multicentre retrospective cohort study", Clin Microbiol Infect, 29, pp.943~ (2023)
  54. Chorazka M, "Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection", PLoS One, 16, pp.e0253161~ (2021)
  55. Li Y, "Adjusting for case under-ascertainment in estimating RSV hospitalisation burden of older adults in high-income countries : a systematic review and modelling study", Infect Dis Ther, 12, pp.1137~1149 (2023)
  56. Sharp A, "Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England", Influenza Other Respir Viruses, 16, pp.125~131 (2022)
  57. Tseng HF, "Severe morbidity and short-and mid-to long-term mortality in older adults hospitalized with respiratory syncytial virus infection", J Infect Dis, 222, pp.1298~1310 (2020)
  58. Branche AR, "Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults", Influenza Other Respir Viruses, 16, pp.1151~1160 (2022)
  59. Ackerson B, "Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults", Clin Infect Dis, 69, pp.197~203 (2019)
  60. Seo YB, "Epidemiologic differences of four major respiratory viruses between children, adolescents, and adults in Korea", J Infect Chemother, 20, pp.672~677 (2014)
  61. Kwon YS, "Risk of mortality associated with respiratory syncytial virus and influenza infection in adults", BMC Infect Dis, 17, pp.785~ (2017)
  62. Seo YB, "Etiology and clinical outcomes of acute respiratory virus infection in hospitalized adults", Infect Chemother, 46, pp.67~76 (2014)
  63. Park SY, "Factors predicting life-threatening infections with respiratory syncytial virus in adult patients", Infect Dis(Lond), 49, pp.333~340 (2017)
  64. Coussement J, "Characteristics and outcomes of patients in the ICU with respiratory syncytial virus compared with those with influenza infection : a multicenter matched cohort study", Chest, 161, pp.1475~1484 (2022)
  65. Choi SH, "Viral infection in patients with severe pneumonia requiring intensive care unit admission", Am J Respir Crit Care Med, 186, pp.325~332 (2012)
  66. Hong HL, "Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia", PLoS One, 9, pp.e95865~ (2014)
  67. Kim HJ, "Respiratory virus of severe pneumonia in South Korea : prevalence and clinical implications", PLoS One, 13, pp.e0198902~ (2018)
  68. Falsey AR, "Respiratory syncytial virus infection in adults", Clin Microbiol Rev, 13, pp.371~384 (2000)
  69. Jensen TO, "Outbreak of respiratory syncytial virus(RSV)infection in immunocompromised adults on a hematology ward", J Med Virol, 88, pp.1827~1831 (2016)
  70. Jones BL, "Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults", J Hosp Infect, 44, pp.53~57 (2000)
  71. Baier C, "Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology", GMS Hyg Infect Control, 13, pp.Doc08~ (2018)
  72. Lavergne V, "Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program", Bone Marrow Transplant, 46, pp.137~142 (2011)
  73. Park WJ, "Respiratory syncytial virus outbreak in the basic military training camp of the Republic of Korea air force", J Prev Med Public Health, 48, pp.10~17 (2015)
  74. De Francesco MA, "Circulation of respiratory viruses in hospitalized adults before and during the COVID-19 pandemic in Brescia, Italy : a retrospective study", Int J Environ Res Public Health, 18, pp.9525~ (2021)
  75. Branche AR, "Why making a diagnosis of respiratory syncytial virus should matter to clinicians", Clin Infect Dis, 69, pp.204~206 (2019)
  76. Fowlkes A, "Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011", J Infect Dis, 209, pp.1715~1725 (2014)
  77. Falsey AR, "Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults", J Am Geriatr Soc, 44, pp.71~73 (1996)
  78. Binder W, "RSV in adult ED patients : Do emergency providers consider RSV as an admission diagnosis?", Am J Emerg Med, 35, pp.1162~1165 (2017)
  79. Chartrand C, "Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection : systematic review and meta-analysis", J Clin Microbiol, 53, pp.3738~3749 (2015)
  80. Popow-Kraupp T, "Diagnosis of respiratory syncytial virus infection", Open Microbiol J, 5, pp.128~134 (2011)
  81. Falsey AR, "Diagnosis of respiratory syncytial virus infection : comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness", J Clin Microbiol, 40, pp.817~820 (2002)
  82. Onwuchekwa C, "Underascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations : a systematic literature review and meta-analysis", J Infect Dis, 228, pp.173~184 (2023)
  83. Broberg EK, "Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016", Euro Surveill, 23, pp.17~00284 (2018)

관련 논문AI추천

Etiology and Clinical Outcomes of Acute Respiratory Virus Infection in Hospitalized Adults김우주, 김인선, 서유빈, 송준영, 양태운, 정희진, 최민주, 홍경욱대한감염학회 · Infection and Chemotherapy2014 · 제46권 제2호Human Metapneumovirus: A Comprehensive Epidemiological Analysis of a Global Respiratory ThreatBhattacharjee Samiksha, Bhattacharya Sudip, Singh Alok대한감염학회 · Infection and Chemotherapy2025 · 제57권 제2호Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines송준영, 허중연대한감염학회 · Infection and Chemotherapy2018 · 제50권 제4호면역저하 성인에서 발생한 호흡기 세포융합바이러스 하기도 감염 2예기세윤, 김우주, 노지윤, 송준영, 이순재, 이창규, 정희진, 최원석대한감염학회 · Infection and Chemotherapy2006 · 제38권 제4호A Retrospective Study Investigating Risks of Acute Respiratory Distress Syndrome and Mortality Following Human Metapneumovirus Infection in Hospitalized Adults경선영, 김유진, 박정웅, 정성환, 황현정대한중환자의학회 · Acute and Critical Care2017 · 제32권 제2호Innate immune recognition of respiratory syncytial virus infection김태훈, 이흥규생화학분자생물학회 · BMB Reports2014 · 제47권 제4호

이 간행물의 다른 논문 (16건)

Identification and Antimicrobial Susceptibilities for Patients with Non-tuberculous Mycobacteria Infection in Jeju Island: Single-Center Retrospective Study이종후, Kim Misun, Kim Miok, Kim Changhwan, Seong Gil Myeong, Kang Myeong Jin, Yoo Jeong Rae, 이재천, 허상택pp. 13-24Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA.1 in Older IndividualsLee Kyung-Shin, 이창섭, Kim Min-Kyung, Park Jun-Sun, Jeon Jaehyun, Um Jihye, Choi Youn Young, Sung Ho Kyung, Jang Hee-Chang, Chin BumSik, Kim Choon Kwan, Oh Myung-donpp. 25-36Comparative Effects of Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines in The Prevention of Genotype-Specific Infection: A Systematic Review and Network Meta-AnalysisOh Jin-Kyoung, Choe Young June, Kim Jimin, Park Jungeun, Yu Su-Yeon, Shim Eunha, Park Mihai, Cho Jahyun, Cheong Chelimpp. 37-46No Significant Differences in Presepsin Levels According to the Causative Microorganism of Bloodstream InfectionLee Beomki, 이남용, 신태건, Park Jong Eun, Yoon Sun Joo, Park Chi-Min, 강은숙pp. 47-56Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage TherapyLee Shinwon, Iredell Jonathan R, Myung Heejoon, Lin Ruby C Y, Lynch Stephaniepp. 57-65
원문 보기